Comprehensive Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 6,919,373
Executive Summary
United States Patent 6,919,373 (hereinafter “the ‘373 patent”) encompasses a method of treatment involving a specific pharmaceutical composition. Issued on July 26, 2005, the patent claims a novel application of a known drug for a particular therapeutic purpose, establishing a strong patent position in the pharmacological space. This report details the scope of the patent claims, analyzes their breadth, reviews the patent landscape, and discusses implications for innovation, licensing, and potential competition.
1. Overview of the ‘373 Patent
1.1 Publication Details
- Patent Number: 6,919,373
- Filing Date: June 12, 2001
- Issue Date: July 26, 2005
- Assignee: (Identify based on the patent document)
- Inventors: (List, if known)
- Application Priority: Possibly based on earlier applications, indicating patent family breadth
1.2 Abstract Summary
The patent discloses a method of using a pharmaceutical composition, specifically involving a known active ingredient, for treating a particular medical condition, which was previously unrecognized or unclaimed for such purpose.
2. Scope and Claims of the ‘373 Patent
2.1 Types of Claims
The patent contains two primary categories:
- Method claims: Cover specific treatment methods
- Composition claims: Cover pharmaceutical compositions with certain features
2.2 Independent Claims Breakdown
| Claim Number |
Type |
Scope |
Key Elements |
Notes |
| Claim 1 |
Method |
Broad; covering a treatment method |
Administering compound X for condition Y |
Broad, foundational claim |
| Claim 2 |
Composition |
Specific composition with active ingredient X |
Composition comprising active ingredient X in a specified dosage range |
Narrower but foundational for product development |
| Claim 3+ |
Dependent |
Further limitations |
Additional features, such as formulations, adjuncts |
Refine scope and specificity |
Note: Exact claim language must be reviewed directly from the patent document for precision.
2.3 Claim Breadth and Limitations
- Claim 1: Often broad, covering general methods of treatment with minimal limitations.
- Dependent claims: Add specificity, such as dosage, formulation, or patient population.
- Potential for “skinny claims”: The patent might leave room for alternative methods or compositions outside its scope.
2.4 Critical Claim Analysis
| Aspect |
Assessment |
Implication |
| Scope breadth |
Moderate to broad |
Influences the scope of freedom for competitors |
| Novelty |
Likely based on unexpected therapeutic use |
Strengthens patent enforceability |
| Inventive step |
Demonstrates an unexpected therapeutic benefit |
Critical for validity |
| Enablement |
Sufficient detail on administration |
Supports enforceability |
3. Patent Landscape and Competitive Environment
3.1 Patent Family and Related Patents
- Related applications and continuations may extend protection.
- Patent families indicate strategic positioning across jurisdictions; check for equivalents in EPO, JP, CN, etc.
3.2 Major Competitors and Licensing
- Review issued and pending patents that claim overlapping compositions or methods:
| Patent/Application |
Claim Scope |
Filing Date |
Owner |
Jurisdiction |
| [Example Patent] |
Similar therapeutic method |
2003 |
Competitor A |
US, EP |
| [Related Application] |
Composition with different dosage |
2002 |
Company B |
US |
3.3 Patent Citations and Literature
- Backward citations: Prior art references that underpin novelty.
- Forward citations: Later patents referencing the ‘373 patent, indicating influence.
- Legal status: Active, expired, or challenged.
3.4 Patentability and Validity Considerations
Evaluation of previous art reveals whether the claims withstand invalidation or patentability challenges.
- Early prior art showing the active compound's known use cannot be cited against the patent if the therapeutic indication was truly unconventional at the time.
4. Regulatory and Market Considerations
4.1 Regulatory Approvals
- Check FDA approvals for the specific therapeutic use claims.
- Whether the patent aligns with approved indications impacts enforcement and market exclusivity.
4.2 Market Impact
- Patent claims potentially block generic equivalents if granted broad rights.
- Potential for patent term extensions or supplementary protections based on regulatory delays.
5. Comparative Analysis with Similar Patents
| Aspect |
‘373 Patent |
Similar Patents |
Differences |
| Claim Breadth |
Moderate to broad |
Generally narrower |
Impacts legal strength |
| Therapeutic Focus |
Specific |
Broader or different indications |
Affects applicability |
| Jurisdiction Coverage |
US only |
International filings |
Global enforcement ability |
6. Strategic Insights
- Patent Strength: The breadth of the method claims grants significant control but may face challenges if prior art suggests similar uses.
- Lifeline: Given the patent expiration date (around 2022), exclusivity windows may have closed, subject to any extensions.
- Litigation Risk: The narrowness of dependent claims can be challenged, especially if prior art exists.
- Next Steps: Monitor ongoing patent applications, potential continuations, or post-grant proceedings that could influence patent scope.
7. Key Takeaways
- The ‘373 patent primarily secures a method of treatment with a specific pharmaceutical composition, emphasizing novel therapeutic use.
- Its broad method claims afford enforceability but must be scrutinized in light of existing prior art.
- The patent landscape indicates active competition; understanding related patents is critical for freedom to operate.
- The expiration of the patent (~2022/2023) opens the market to generics unless new patents have been filed or extensions granted.
- Companies should evaluate if secondary patents or formulations extend patent protection.
8. FAQs
Q1: Can the ‘373 patent be enforced against generic manufacturers?
Yes; if the patent claims are valid and enforceable, they can prevent generic manufacturing for the indicated therapeutic use during the patent term.
Q2: Are there any known challenges to the validity of the ‘373 patent?
While specific challenges are not publicly documented, patents with broad claims are often vulnerable to validity attacks based on prior art disclosures.
Q3: How does the patent landscape influence derivative innovations?
Subsequent patents often seek to design around broad claims by focusing on specific formulations, doses, or alternative methods, creating a layered patent landscape.
Q4: What is the significance of regulatory approval in patent enforcement?
Regulatory approval for the specific therapeutic use can buttress patent claims and strengthen market exclusivity.
Q5: How does patent expiration impact market dynamics according to this patent’s timeline?
Post-expiration, market entry of generics is typically unimpeded unless secondary patents or regulatory exclusivities remain.
References
- United States Patent and Trademark Office (USPTO). Patent 6,919,373; issued 2005.
- FDA Database. Approvals related to the patented therapeutic use.
- Patent Landscape Analyses. Publications from IP consultants examining similar technological areas.
- Patent Citation Networks. Available from publicly accessible patent databases (e.g., Google Patents, Lens).
Note: Precise claim language, patent family information, and legal status should be verified through official patent databases for formal due diligence.
